By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

BioMarin Pharmaceutical Inc. 

105 Digital Drive

Novato  California  94949  U.S.A.
Phone: 415-506-6700 Fax: 415-382-7427


SEARCH JOBS


Industry
Biotechnology






Company News
BioMarin Pharmaceutical Inc. (BMRN)'s VIMIZIM® (Elosulfase Alfa) Approved In Brazil For Treatment Of Morquio A Syndrome 12/10/2014 7:04:14 AM
FDA Grants BioMarin Pharmaceutical Inc. (BMRN) Orphan Drug Designation For NAGLU Fusion Protein, BMN 250, For The Treatment Of MPS IIIB (Sanfilippo Syndrome Type B) 12/10/2014 7:02:37 AM
BioMarin Pharmaceutical Inc. (BMRN) To Highlight Breadth Of Innovative Development Pipeline At Analyst And Investor Day On December 10th In New York 12/9/2014 12:32:35 PM
BioMarin Pharmaceutical Inc. (BMRN)''s VIMIZIM® (Elosulfase Alfa) Approved In Australia For Treatment Of Morquio A Syndrome 12/8/2014 7:50:25 AM
BioMarin Pharmaceutical Inc. (BMRN) To Host Analyst And Investor Day On December 10th In New York 12/5/2014 9:01:24 AM
Analyst: First Quarter of 2015 Crucial to ProSensa Holding N.V. (RNA), BioMarin Pharmaceutical Inc. (BMRN) Deal 11/25/2014 4:37:51 PM
BioMarin Pharmaceutical Inc. (BMRN), ProSensa Holding N.V. (RNA) Marriage Makes Sense for Investors If Regulatory Hurdles Can Be Overcome 11/24/2014 1:41:33 PM
BioMarin Pharmaceutical Inc. (BMRN) Acquires ProSensa Holding N.V. (RNA) For Up To $840M; Gaining Experimental Drisapersen 11/24/2014 5:41:26 AM
BioMarin Pharmaceutical Inc. (BMRN) To Attend Upcoming Investor Conferences 11/19/2014 12:51:37 PM
Biotech Investors Bullish On Large Cap; Citi Adds Vertex Pharmaceuticals (MA) (VRTX), BioMarin Pharmaceutical Inc. (BMRN) and Tesaro, Inc. (TSRO) To Most Preferred 11/14/2014 3:27:58 PM
12345678910...
//-->